(Q22251464)

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Emotional reactivity to daily life stress in psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Diagnosing schizophrenia in the initial prodromal phase

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Brain volume changes in first-episode schizophrenia: a 1-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

The association of inequality with the incidence of schizophrenia--an ecological study

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Early detection and secondary prevention of psychosis: facts and visions

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

The epidemiology of onset and course of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Abnormal and normal obsessions

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Abnormal and normal obsessions—A replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

A simple (or simplistic?) cognitive model for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

The self, attributional processes and abnormal beliefs: towards a model of persecutory delusions

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Connecting neurosis and psychosis: the direct influence of emotion on delusions and hallucinations

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Hippocampal volume in familial and nonfamilial schizophrenic probands and their unaffected relatives

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Increased dopamine transmission in schizophrenia: relationship to illness phases

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

The developmental 'risk factor' model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Development, disease and degeneration in schizophrenia: a unitary pathophysiological model

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Genes for schizophrenia? Recent findings and their pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Child development risk factors for adult schizophrenia in the British 1946 birth cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Behavioral effects of neonatal and adult excitotoxic lesions of the mediodorsal thalamus in the adult rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

The continuity of psychotic experiences in the general population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Catching up on schizophrenia: natural history and neurobiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Treatment of the schizophrenia prodrome: is it presently ethical?

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Psychotic symptoms in non-clinical populations and the continuum of psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

The schizophrenia prodrome: treatment and high-risk perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Non-reduction in hippocampal volume is associated with higher risk of psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Does dysplasia cause anatomical dysconnectivity in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Strauss (1969) revisited: a psychosis continuum in the general population?

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Temporal lobe volume changes in people at high risk of schizophrenia with psychotic symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

A cognitive model of the positive symptoms of psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Pathways to schizophrenia: the impact of environmental factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

The molecular genetics of schizophrenia: new findings promise new insights

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

fMRI correlates of state and trait effects in subjects at genetically enhanced risk of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

The assessment of "prodromal schizophrenia": unresolved issues and future directions

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Does dopamine sensitization underlie the association between schizophrenia and drug abuse?

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Hallucinatory experiences and onset of psychotic disorder: evidence that the risk is mediated by delusion formation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Developmental time course in human infants and infant monkeys, and the neural bases of, inhibitory control in reaching.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Is schizophrenia a neurodevelopmental disorder?

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Meta-analysis of regional brain volumes in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Obstetric complications and schizophrenia: historical and meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Schizophrenia and migration: a meta-analysis and review

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

The Genetics of Schizophrenia is the Genetics of Neurodevelopment

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

People at risk of schizophrenia. Sample characteristics of the first 100 cases in the Edinburgh High-Risk Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Understanding the excess of psychosis among the African-Caribbean population in England. Review of current hypotheses

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Independent course of childhood auditory hallucinations: a sequential 3-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Stress and the progression of the developmental hypothesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Causal association between cannabis and psychosis: examination of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Pituitary volume in psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Stimulant psychosis: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

Prevalence and correlates of self-reported psychotic symptoms in the British population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021

The incidence and outcome of subclinical psychotic experiences in the general population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SCHRES.2005.02.007

7 January 2021